Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

PRIMAQUINE 26.3 MG TABLET

Primaquine Phosphate
$1.9639per EA

Strength

15 mg/1

Manufacturer

Unichem Pharmaceuticals (USA) Inc.

NDC

76385010201

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

5/21/2025

Active Ingredients

PRIMAQUINE PHOSPHATE

Approval Type

Generic (ANDA)

FDA Application

ANDA204476

On Market Since

8/1/2014

Pharmacological Classes

Antimalarial

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

N/A

5Y

N/A

All

+17.9%

Generic Alternatives

1 alternative • Same active ingredient

PRIMAQUINE 26.3 MG TABLET
Generic
00024159601•Sanofi-Aventis U.S. LLC
$1.9639

Related Drugs

Same classification

HYDROXYCHLOROQUINE 200 MG TAB
Generic
00093240101•Teva Pharmaceuticals USA Inc.
$0.1622
per EA
HYDROXYCHLOROQUINE 200 MG TAB
Generic
00904704606•Major Pharmaceuticals
$0.1622
per EA
HYDROXYCHLOROQUINE 200 MG TAB
Generic
00904704661•Major Pharmaceuticals
$0.1622
per EA
HYDROXYCHLOROQUINE 200 MG TAB
Generic
16571011201•Rising Pharma Holdings Inc.
$0.1622
per EA
HYDROXYCHLOROQUINE 200 MG TAB
Generic
16571011250•Rising Pharma Holdings Inc.
$0.1622
per EA
HYDROXYCHLOROQUINE 200 MG TAB
Generic
16714011001•NorthStar Rx LLC
$0.1622
per EA
HYDROXYCHLOROQUINE 200 MG TAB
Generic
16714011002•NorthStar Rx LLC
$0.1622
per EA
HYDROXYCHLOROQUINE 200 MG TAB
Generic
16729048501•Accord Healthcare Inc.
$0.1622
per EA
HYDROXYCHLOROQUINE 200 MG TAB
Generic
16729048516•Accord Healthcare Inc.
$0.1622
per EA
HYDROXYCHLOROQUINE 200 MG TAB
Generic
43598072101•Dr. Reddy's Laboratories Inc.
$0.1622
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy